JP2023134493A - 呼吸器疾患の治療のための化合物 - Google Patents

呼吸器疾患の治療のための化合物 Download PDF

Info

Publication number
JP2023134493A
JP2023134493A JP2023101906A JP2023101906A JP2023134493A JP 2023134493 A JP2023134493 A JP 2023134493A JP 2023101906 A JP2023101906 A JP 2023101906A JP 2023101906 A JP2023101906 A JP 2023101906A JP 2023134493 A JP2023134493 A JP 2023134493A
Authority
JP
Japan
Prior art keywords
compound according
mmol
alkyl
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023101906A
Other languages
English (en)
Japanese (ja)
Inventor
ウィリアムズ、スペンサー
Williams Spencer
シャー、サヤリ
Shah Sayali
ハッキ、ザリヘ
Hakki Zalihe
スチュワート、アラステア
Stewart Alastair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901611A external-priority patent/AU2017901611A0/en
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of JP2023134493A publication Critical patent/JP2023134493A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2023101906A 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物 Pending JP2023134493A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AU2017901611 2017-05-03
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
AU2017901647 2017-05-05
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
JP2019560254A JP7788128B2 (ja) 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019560254A Division JP7788128B2 (ja) 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物

Publications (1)

Publication Number Publication Date
JP2023134493A true JP2023134493A (ja) 2023-09-27

Family

ID=64015663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023101906A Pending JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Country Status (8)

Country Link
US (2) US20200079757A1 (enExample)
EP (1) EP3619204B1 (enExample)
JP (1) JP2023134493A (enExample)
CN (1) CN110753688A (enExample)
AU (3) AU2018262108A1 (enExample)
FI (1) FI3619204T3 (enExample)
PT (1) PT3619204T (enExample)
WO (1) WO2018201192A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4591936A3 (en) 2015-03-23 2025-10-15 Tianli Biotech Pty Ltd Treatment of respiratory diseases
WO2020093098A1 (en) * 2018-11-07 2020-05-14 The University Of Melbourne Novel compounds for the treatment of respiratory diseases
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US6335340B1 (en) * 1997-12-19 2002-01-01 Smithkline Beecham Corporation compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses
EP2493876B1 (en) * 2009-10-28 2014-02-12 Pfizer Inc Imidazole derivatives as casein kinase inhibitors
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
EP4591936A3 (en) * 2015-03-23 2025-10-15 Tianli Biotech Pty Ltd Treatment of respiratory diseases

Also Published As

Publication number Publication date
AU2022202774A1 (en) 2022-05-19
PT3619204T (pt) 2025-10-29
AU2024200521A1 (en) 2024-02-15
US20200079757A1 (en) 2020-03-12
EP3619204A1 (en) 2020-03-11
US20220380343A1 (en) 2022-12-01
AU2018262108A1 (en) 2019-11-21
WO2018201192A1 (en) 2018-11-08
AU2024200521B2 (en) 2025-10-02
EP3619204A4 (en) 2021-03-24
FI3619204T3 (fi) 2025-11-06
EP3619204B1 (en) 2025-10-01
JP2020518621A (ja) 2020-06-25
CN110753688A (zh) 2020-02-04

Similar Documents

Publication Publication Date Title
US11975005B2 (en) Treatment of respiratory diseases
JP2023134493A (ja) 呼吸器疾患の治療のための化合物
JP7575099B2 (ja) 呼吸器疾患の処理のための新規な化合物
CN111620815B (zh) 手性氯喹、羟氯喹和其衍生物及其制备方法与用途
JP7788128B2 (ja) 呼吸器疾患の治療のための化合物
HK40023875A (en) Compounds for the treatment of respiratory diseases
HK40023875B (en) Compounds for the treatment of respiratory diseases
HK40058742A (en) Treatment of respiratory diseases
HK40059876A (en) Treatment of respiratory diseases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230721

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230721

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20230816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230816

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20240703